Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleNuclear Oncology

Monitoring Response to Therapy with Thallium-201 and Technetium-99m-Sestamibi SPECT in Nasopharyngeal Carcinoma

Lale Kostakoglu, Ugur Uysal, Enis Özyar, Mutlu Hayran, Dilek Uzal, Figen B. Demirkazïk, Ayse Kars, Lale Atahan and Coşkun F. Bekdik
Journal of Nuclear Medicine July 1997, 38 (7) 1009-1014;
Lale Kostakoglu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ugur Uysal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enis Özyar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mutlu Hayran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dilek Uzal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Figen B. Demirkazïk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ayse Kars
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lale Atahan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Coşkun F. Bekdik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 38, Issue 7
July 1, 1997
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Monitoring Response to Therapy with Thallium-201 and Technetium-99m-Sestamibi SPECT in Nasopharyngeal Carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Monitoring Response to Therapy with Thallium-201 and Technetium-99m-Sestamibi SPECT in Nasopharyngeal Carcinoma
Lale Kostakoglu, Ugur Uysal, Enis Özyar, Mutlu Hayran, Dilek Uzal, Figen B. Demirkazïk, Ayse Kars, Lale Atahan, Coşkun F. Bekdik
Journal of Nuclear Medicine Jul 1997, 38 (7) 1009-1014;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Monitoring Response to Therapy with Thallium-201 and Technetium-99m-Sestamibi SPECT in Nasopharyngeal Carcinoma
Lale Kostakoglu, Ugur Uysal, Enis Özyar, Mutlu Hayran, Dilek Uzal, Figen B. Demirkazïk, Ayse Kars, Lale Atahan, Coşkun F. Bekdik
Journal of Nuclear Medicine Jul 1997, 38 (7) 1009-1014;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Differentiating osteoradionecrosis from nasopharyngeal carcinoma tumour recurrence using 99Tcm-sestamibi SPECT/CT
  • Interpretation of scintigraphic findings of oral malignant tumours with a new scanning agent of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (Tc-99m-MIBI)
  • Scintigraphy for interpretation of malignant tumours of the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile (Tc-MIBI) and thallium-201-chloride (Tl-201)
  • Google Scholar

More in this TOC Section

  • Dose Escalation Trial of Indium-111-Labeled Anti-Carcinoembryonic Antigen Chimeric Monoclonal Antibody (Chimeric T84.66) in Presurgical Colorectal Cancer Patients
  • Optimized Conditions for Chelation of Yttrium-90-DOTA Immunoconjugates
  • Quantifying the Radiation Dosage to Individual Skeletal Lesions Treated with Samarium-153-EDTMP
Show more Nuclear Oncology

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire